I do not just run marketing. I build revenue engines.
Fractional and Interim CMO for companies where growth needs to scale, not stall. 20+ years across PE-backed and founder-led B2B and B2C SaaS, fintech, cybersecurity and healthtech.
I am a Fractional CMO, Interim CMO and commercial growth advisor based in London. For the past 20+ years I have led marketing and commercial functions inside PE-backed and founder-led technology businesses across B2B and B2C SaaS, fintech, cybersecurity, healthtech and adtech.
My career started somewhere unusual for a tech CMO. I trained in clinical healthcare and spent my foundation years at Pfizer, Bristol-Myers Squibb and GSK, running global brands like Lipitor across 17 countries. That grounding in regulated, evidence-based, complex-sale markets is exactly why I am credible today in fintech, healthtech and cybersecurity, where the buyer is technical, the risk is real and the marketing has to hold up to scrutiny.
I hold a Cambridge MBA. Most recently I was Group CMO at Vyntra, a PE-backed fintech SaaS business, where I led the merger rebrand of NetGuardians and Intix and helped scale revenue from €10M to €40M. Before that I was Global Marketing Director at Telmar. I have also co-founded and scaled a venture-backed consumer platform to 2M users.
"The companies that win will not be the ones with the most AI tools. They will be the ones that orchestrate AI, people and systems better than everyone else."
Twenty years operating inside the engine room.
- 2026 to presentFractional and Interim CMO, AdvisorTherefour UK
Advises CEOs of VC and PE-backed SaaS, fintech and digital health companies on GTM, pricing, positioning and demand generation. Current advisory portfolio includes JBL Software and Voxa Health.
- 2023 to 2026Group CMOVyntra (PE-backed fintech SaaS)
Led the merger rebrand of NetGuardians and Intix into Vyntra across 250+ employees. Grew marketing-generated pipeline by 30%, delivered 6x marketing ROI and supported revenue growth from €10M to €40M. Led a global team of 10.
- 2020 to 2022Global Marketing DirectorTelmar (PE-backed adtech SaaS)
Led 6 global product launches across 4 continents contributing to 9% revenue growth. Repriced 50+ products across 9 territories. Built and led a 25-person global marketing team. 5x marketing ROI in 8 months.
- 2015 to 2020Co-founder and CMOSnapnSave (B2B2C PaaS)
Scaled a digital rewards platform to 2M consumers. Supported 3 rounds of venture funding. Partnerships with Vodacom and WeChat. Customer acquisition cost of around $2. Retention improved by 15%.
- 1997 to 2015Foundation yearsPfizer, BMS, GSK, Virgin Active, Zoona
Managed the Lipitor brand ($3B revenue) across 17 countries at Pfizer with an £80M global budget. Led pre-launch strategy for a diabetes brand with a £50M budget at BMS. Consumer strategy roles at Virgin Active and Zoona.
Selected awards.
Where the work compounds.
Regulated, complex, technical B2B and B2C businesses where commercial leverage is engineered, not improvised.
How I operate.
Outcome over activity
Every quarter is measured by the commercial result the business needs next, not by how busy the team looks.
Systems over heroics
Predictable revenue is engineered. Heroic effort does not scale. Operating systems do.
AI as leverage, not novelty
AI earns its place when it removes friction and gives leaders sharper decisions faster.
Executive accountability
I operate as a member of the leadership team. Board-level thinking, hands-on delivery.
Exploring a Fractional or Interim CMO engagement?
Every conversation is treated in confidence.
Let's Talk